Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knoll

Showing results (11-20 of 4,329) with videos related to

Pageof 433
Sort By:
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1986
Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchangedJ Timar, B Knoll, J Knoll
Acta Physiologica Academiae Scientiarum Hungaricae|January 1, 1970
Pharmacological studies on para-bromo-methamphetamine (V-111) and LSDJ Knoll, E S Vizi, B Knoll
Zeitschrift Fur Unfallmedizin Und Berufskrankheiten. Revue De Medecine Des Accidents Et Des Maladies Professionelles|October 29, 2010
On the question of so-called post-traumatic Raynaud's DiseaseH KNOLL
Orvosi Hetilap|May 14, 1978
[Azidomorphins and homopyrimidazoles: a new attempt at finding an ideal analgesic]J Knoll
Mechanisms of Ageing and Development|May 13, 1985
The facilitation of dopaminergic activity in the aged brain by (-)deprenyl. A proposal for a strategy to improve the quality of life in senescenceJ Knoll
Monographs of the American Association on Mental Retardation|January 1, 1992
Being a family. The experience of raising a child with a disability or chronic illnessJ Knoll
Advances in Neurology|January 1, 1987
Critical role of MAO inhibition in Parkinson's diseaseJ Knoll
Medicinal Research Reviews|January 1, 1987
Satietins, alpha 1-glycoproteins in human plasma with potent, long-lasting and selective anorectic activityJ Knoll
The Mount Sinai Journal of Medicine, New York|January 1, 1988
Extension of life span of rats by long-term (-)deprenyl treatmentJ Knoll
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Neurophysiologic parameters of uremic polyneuropethy as criteria for an optimization of chronic dialysis treatment]O Knoll
Pageof 433

Showing results (11-20 of 4,329) with videos related to

Sort By:
Pageof 433
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1986
Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchangedJ Timar, B Knoll, J Knoll
Acta Physiologica Academiae Scientiarum Hungaricae|January 1, 1970
Pharmacological studies on para-bromo-methamphetamine (V-111) and LSDJ Knoll, E S Vizi, B Knoll
Zeitschrift Fur Unfallmedizin Und Berufskrankheiten. Revue De Medecine Des Accidents Et Des Maladies Professionelles|October 29, 2010
On the question of so-called post-traumatic Raynaud's DiseaseH KNOLL
Orvosi Hetilap|May 14, 1978
[Azidomorphins and homopyrimidazoles: a new attempt at finding an ideal analgesic]J Knoll
Mechanisms of Ageing and Development|May 13, 1985
The facilitation of dopaminergic activity in the aged brain by (-)deprenyl. A proposal for a strategy to improve the quality of life in senescenceJ Knoll
Monographs of the American Association on Mental Retardation|January 1, 1992
Being a family. The experience of raising a child with a disability or chronic illnessJ Knoll
Advances in Neurology|January 1, 1987
Critical role of MAO inhibition in Parkinson's diseaseJ Knoll
Medicinal Research Reviews|January 1, 1987
Satietins, alpha 1-glycoproteins in human plasma with potent, long-lasting and selective anorectic activityJ Knoll
The Mount Sinai Journal of Medicine, New York|January 1, 1988
Extension of life span of rats by long-term (-)deprenyl treatmentJ Knoll
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Neurophysiologic parameters of uremic polyneuropethy as criteria for an optimization of chronic dialysis treatment]O Knoll
Pageof 433